- Conditions
- Ovarian Cancer, Non-small Cell Lung Cancer
- Interventions
- TUB-040
- Drug
- Lead sponsor
- Tubulis GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • East Brunswick, New Jersey • New York, New York + 7 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Uterine Endometrial Cancer
- Interventions
- TUB-040 - Dose escalation, TUB-040 - RP2D
- Drug
- Lead sponsor
- Tubulis GmbH
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 4
- States / cities
- Los Angeles, California • East Brunswick, New Jersey • Lake Success, New York + 1 more
- Conditions
- Ovarian Cancer
- Interventions
- TUB-040 + Carbo + BEV
- Drug
- Lead sponsor
- Tubulis GmbH
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 3
- States / cities
- Los Angeles, California • East Brunswick, New Jersey • New York, New York